Senators demand USPTO probe into Gilead allegations

16-12-2019

Rory O'Neill

Senators demand USPTO probe into Gilead allegations

Sundry Photography / Shutterstock.com

The US Patent and Trademark Office (USPTO) is coming under increasing pressure to review allegations that Gilead delayed development of its latest HIV drug in order to maximise profits.


US Patent and Trademark Office, USPTO, Bernie Sanders, Elizabeth Warren, HIV, PrEP, Descovy, Gilead, Truvada

LSIPR